Hikma Pharmaceuticals PLC (HKMPF)

USD 24.06

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 2.87 Billion 2.51 Billion 2.55 Billion 2.34 Billion 2.2 Billion 2.07 Billion
Cost of Revenue 1.48 Billion 1.27 Billion 1.25 Billion 1.14 Billion 1.05 Billion 1.02 Billion
Gross Profit 1.39 Billion 1.23 Billion 1.3 Billion 1.2 Billion 1.14 Billion 1.05 Billion
Operating Expenses 1.04 Billion 756 Million 742 Million 687 Million 655 Million 690 Million
Selling, General and Administrative Expenses 632 Million 509 Million 488 Million 464 Million 494 Million 470 Million
Research and Development Expenses 149 Million 144 Million 143 Million 137 Million 150 Million 147 Million
Other Expenses 259 Million - - - -50.88 Million -59.21 Million
Cost and Expenses 2.5 Billion 2.03 Billion 1.99 Billion 1.82 Billion 1.71 Billion 1.71 Billion
Operating Income 367 Million 282 Million 582 Million 579 Million 493 Million 371 Million
Interest Expense 90 Million 77 Million 69 Million 69 Million 67 Million 80 Million
Income Tax Expense 89 Million 42 Million 124 Million 128 Million 4 Million 8 Million
Earnings before Tax 281 Million 233 Million 544 Million 558 Million 491 Million 293 Million
Net Income 190 Million 188 Million 421 Million 431 Million 486 Million 282 Million
Earnings Per Share Basic 0.86 0.82 1.79 1.95 2.09 1.17
Earnings Per Share Diluted 0.85 0.82 1.78 1.93 2.08 1.17
Weighted Average Shares Outstanding 220.86 Million 224 Million 231 Million 236 Million 242 Million 241 Million
Weighted Average Shares Outstanding (Diluted) 222.36 Million 225 Million 233 Million 238 Million 243 Million 242 Million
Gross Margin 0.48 0.49 0.51 0.51 0.52 0.51
EBIT Margin 0.20 0.28 0.29 0.28 0.30 0.23
Profit Margin 0.07 0.07 0.16 0.18 0.22 0.14
EBITDA 572.46 Million 485 Million 735 Million 796.27 Million 685.35 Million 435.54 Million
Earnings Before Tax Margin 0.13 0.11 0.23 0.25 0.22 0.18

Income Statement Charts